Celia Sequera

Marseille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Establishment of a mouse hepatocellular carcinoma tumoroid panel recapitulating inter- and intra- heterogeneity for disease modelling and combinatorial drug discovery.

Establishment of a mouse hepatocellular carcinoma tumoroid panel recapitulating inter- and intra- heterogeneity for disease modelling and combinatorial drug discovery.

Journal: Cell communication and signaling : CCS
Published: June 03, 2025

Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response.

Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response.

Journal: The Journal of pathology
Published: October 28, 2024

Tracing specificity of immune landscape remodeling associated with distinct anticancer treatments.

Tracing specificity of immune landscape remodeling associated with distinct anticancer treatments.

Journal: iScience
Published: March 03, 2024

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.

Journal: Nature communications
Published: July 13, 2023

MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.

MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.

Journal: Cell death & disease
Published: June 23, 2022

C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process.

C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process.

Journal: International journal of biological sciences
Published: March 24, 2022

Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling.

Enhanced Wild-Type MET Receptor Levels in Mouse Hepatocytes Attenuates Insulin-Mediated Signaling.

Journal: Cells
Published: December 19, 2021

Two is better than one: combinatorial receptor targeting enhances hepatocellular carcinoma (HCC) therapeutic response.

Two is better than one: combinatorial receptor targeting enhances hepatocellular carcinoma (HCC) therapeutic response.

Journal: Hepatobiliary surgery and nutrition
Published: December 07, 2021

C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.

C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.

Journal: Cell death & disease
Published: August 26, 2020

C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation.

C3G Is Upregulated in Hepatocarcinoma, Contributing to Tumor Growth and Progression and to HGF/MET Pathway Activation.

Journal: Cancers
Published: July 28, 2020

ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.

ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma.

Journal: Journal of hepatology
Published: April 10, 2020

How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma.

How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinoma.

Journal: Hepatic oncology
Published: December 19, 2017
Showing 1-12 of 16

Last Updated: 09/26/2026